Relative IL32 expression was determined in patient-matched samples from tumor and non-transformed mucosa adjacent to tumor (52 pairs), obtained from 17 patients with ESCC, 14 with GC, and 21 with CRC using reverse-transcribed quantitative (real-time) polymerase chain reaction (RT-qPCR). Here, IL32 is linked to gastric cancer.